Article

Timolol hemihydrate offers affordable brand-name quality

Author(s):

Cheryl Guttman

When a decision is made to prescribe a topical beta-blocker for monotherapy or as an add-on agent, timolol hemihydrate (Betimol, Santen) offers many advantages that may make it an excellent option.

Related Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
Edward Manche, MD
Related Content
4-Year research validates DOT 0.2 spectacle lenses as early myopia treatment
December 12th 2024

4-Year research validates DOT 0.2 spectacle lenses as early myopia treatment

ROP: Treating and preventing blindness in preterm babies
October 18th 2021

ROP: Treating and preventing blindness in preterm babies

Early vision screening is key to slowing myopia progression in children
November 28th 2024

Early vision screening is key to slowing myopia progression in children

Managing a changing landscape of IRD pediatric cases
May 10th 2021

Managing a changing landscape of IRD pediatric cases

Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease
November 18th 2024

Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease

Cerebral visual impairment is a growing concern in pediatric vision loss
November 14th 2024

Cerebral visual impairment is a growing concern in pediatric vision loss

© 2025 MJH Life Sciences

All rights reserved.